Latest filing published 29 Apr 2022 for Cumberland Pharmaceuticals INC, €37k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 174 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -40.9%Entry US$4.25 · Close at T+365 US$2.51
- -68.4%Entry US$6.94 · Close at T+365 US$2.19
- -23.8%Entry US$3.02 · Close at T+365 US$2.30
- -8.8%Entry US$2.85 · Close at T+365 US$2.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Martin E. Cearnal: trading record in brief
Martin E. Cearnal discloses dealings in Cumberland Pharmaceuticals Inc to SEC (Form 4). Over a trading history stretching from 17 November 2010 to 17 March 2022, the count stands at 196 filings.
On the market, this insider has only ever bought: 174 purchases, €75k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 20 share grants and 1 option exercise. In 2022 alone, the filings show 14 purchases and no sales.
The median purchase comes to €258. 120 out of 174 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 174 purchases with a full 90-day history, the hit rate stands at 36% and the median 90-day move at -14.8%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 29 April 2022, the filings show a transaction worth €37k in Cumberland Pharmaceuticals Inc. The last purchase on record was published on 7 January 2022, which is 1,766 days ago. The median gap between a trade and its publication by SEC (Form 4) is 24 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Martin E. Cearnal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 15,000 shares@ US$2.7479.1% of flowCommon StockSEC:0001209191-22-026154:0
- 90 shares@ US$3.840.1% of flowCommon StockSEC:0001209191-22-002447:1Canonical exit: 2 Mar 2022 (T+90)
- 90 shares@ US$4.470.1% of flowCommon StockSEC:0001209191-22-002447:2Canonical exit: 3 Mar 2022 (T+90)
- 90 shares@ US$4.460.1% of flowCommon StockSEC:0001209191-22-002447:3Canonical exit: 6 Mar 2022 (T+90)
- 90 shares@ US$5.610.1% of flowCommon StockSEC:0001209191-22-002447:4Canonical exit: 7 Mar 2022 (T+90)
- 90 shares@ US$6.150.2% of flowCommon StockSEC:0001209191-22-002447:5Canonical exit: 8 Mar 2022 (T+90)
- 90 shares@ US$5.810.1% of flowCommon StockSEC:0001209191-22-002447:6Canonical exit: 9 Mar 2022 (T+90)
- 90 shares@ US$4.820.1% of flowCommon StockSEC:0001209191-22-002447:7Canonical exit: 10 Mar 2022 (T+90)
- 200 shares@ US$4.360.2% of flowCommon StockSEC:0001209191-22-002447:8Canonical exit: 13 Mar 2022 (T+90)
- 200 shares@ US$4.280.2% of flowCommon StockSEC:0001209191-22-002447:9Canonical exit: 14 Mar 2022 (T+90)
- 200 shares@ US$4.290.2% of flowCommon StockSEC:0001209191-22-002447:10Canonical exit: 15 Mar 2022 (T+90)
- 240 shares@ US$4.530.3% of flowCommon StockSEC:0001209191-22-002447:11Canonical exit: 16 Mar 2022 (T+90)
- 240 shares@ US$4.170.3% of flowCommon StockSEC:0001209191-22-002447:12Canonical exit: 17 Mar 2022 (T+90)
- 314 shares@ US$4.330.4% of flowCommon StockSEC:0001209191-22-002447:13Canonical exit: 20 Mar 2022 (T+90)
- 90 shares@ US$4.140.7% of flowCommon StockSEC:0001209191-22-002447:0Canonical exit: 1 Mar 2022 (T+90)
- 105 shares@ US$2.630.1% of flowCommon StockSEC:0001209191-21-067878:1Canonical exit: 31 Jan 2022 (T+90)
- 105 shares@ US$2.710.1% of flowCommon StockSEC:0001209191-21-067878:2Canonical exit: 1 Feb 2022 (T+90)
- 105 shares@ US$2.730.1% of flowCommon StockSEC:0001209191-21-067878:3Canonical exit: 2 Feb 2022 (T+90)
- 105 shares@ US$2.710.1% of flowCommon StockSEC:0001209191-21-067878:4Canonical exit: 3 Feb 2022 (T+90)
- 105 shares@ US$2.950.1% of flowCommon StockSEC:0001209191-21-067878:5Canonical exit: 6 Feb 2022 (T+90)
- 105 shares@ US$3.210.1% of flowCommon StockSEC:0001209191-21-067878:6Canonical exit: 7 Feb 2022 (T+90)
- 105 shares@ US$2.940.1% of flowCommon StockSEC:0001209191-21-067878:7Canonical exit: 8 Feb 2022 (T+90)
- 105 shares@ US$2.830.1% of flowCommon StockSEC:0001209191-21-067878:8Canonical exit: 9 Feb 2022 (T+90)
- 105 shares@ US$2.670.1% of flowCommon StockSEC:0001209191-21-067878:9Canonical exit: 10 Feb 2022 (T+90)
- 105 shares@ US$2.710.1% of flowCommon StockSEC:0001209191-21-067878:10Canonical exit: 13 Feb 2022 (T+90)
25 of 194 declarations
